EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Quality of Life of Colorectal Cancer Patients Treated with Chemotherapy

Monika Ziętarska iD, Sylwia Małgorzewicz iD

Nutrients · 2026

DOI: 10.3390/nu18020191 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Monika Ziętarska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Pediatrics, Hematology and Oncology, University Clinical Center in Gdańsk, Dębinki 7, 80-952 Gdansk, Poland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cachexia, Colorectal Neoplasms, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nutricia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Colorectal cancer (CRC) is associated with anorexia–cachexia syndrome, which negatively affects health-related quality of life (HRQoL). This study aimed to evaluate HRQoL and functional status in CRC patients undergoing chemotherapy who were eligible for oral nutritional supplementation (ONS).

Methods

In this prospective, randomized study, 72 patients with stage II–IV CRC were enrolled (40 intervention group [IG], 32 control group [CG]). IG received ONS (2 × 125 mL/day, 600 kcal, 36 g protein) for 12 weeks, while CG received dietary counseling only. HRQoL was assessed every 4 weeks with the Functional Assessment of Anorexia/Cachexia Therapy (FAACT, version 4.0). Functional status was evaluated with the Karnofsky scale. Nutritional status was assessed using the Subjective Global Assessment (SGA), Nutritional Risk Screening (NRS-2002), and body mass index (BMI), and appetite was assessed on a visual analogue scale (VAS). Clinical Trial Registration: ClinicalTrials.gov, NCT02848807.

Results

Mean FAACT score did not differ significantly between groups over 12 weeks (101.0 ± 22.8, 95% CI: 94.6–107.4 vs. 105.1 ± 21.4, 95% CI: 99.1–111.1; p = 0.06). However, the observed difference corresponded to an effect size at the lower bound of the moderate range. However, minimally important difference (MID) analysis demonstrated that clinically meaningful improvement was significantly more frequent in IG than in CG for global FAACT (32% vs. 8%; p = 0.03, OR = 5.50, 95% CI: 1.10–27.62, φ = 0.29), physical well-being (32% vs. 8%; p = 0.03, OR = 5.50, 95% CI: 1.10–27.62, φ = 0.29), and emotional well-being (38% vs. 4%; p = 0.002, OR = 14.86, 95% CI: 1.79–123.36, φ = 0.40). Functional well-being and anorexia/cachexia concerns showed favorable, but nonsignificant, trends (FWB improvement: 29% vs. 8%, p = 0.05, OR = 4.79, 95% CI: 0.95–24.27, φ = 0.26; ACS deterioration: 3% vs. 20%, p = 0.07, OR = 0.12, 95% CI: 0.01–1.11, φ = 0.28). HRQoL correlated positively with nutritional status, appetite, and functional performance, while Karnofsky scores remained stable in both groups.

Conclusions

ONS did not significantly change the mean QoL scores at the group level but increased the proportion of patients achieving clinically meaningful improvement, particularly in the physical and emotional domains. These findings suggest that ONS may benefit selected patients who respond to nutritional interventions, underscoring the clinical relevance of individualized nutrition strategies in oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCachexiaColorectal NeoplasmsQuality of LifeAgedFemaleHumansMaleMiddle AgedAnorexiaAppetiteDietary SupplementsNutrition AssessmentNutritional StatusProspective Studies

Stichwörter der Autor:innen

colorectal cancerfunctional statushealth-related quality of lifeoral nutritional supplementspre-cachexia

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Clinic of Pediatrics, Hematology and Oncology, University Clinical Center in Gdańsk, Dębinki 7, 80-952 Gdansk, Poland.
  • Department of Clinical Nutrition, Medical University of Gdańsk, Dębinki 7, 80-211 Gdansk, Poland.

ORCID-Profile: Monika Ziętarska, Sylwia Małgorzewicz

Förderung

  • Nutricia Foundation

Zitieren

APA

Ziętarska, M., & Małgorzewicz, S. (2026). Quality of Life of Colorectal Cancer Patients Treated with Chemotherapy. Nutrients. https://doi.org/10.3390/nu18020191

Vancouver

Ziętarska M, Małgorzewicz S. Quality of Life of Colorectal Cancer Patients Treated with Chemotherapy. Nutrients. 2026. doi:10.3390/nu18020191

BibTeX
@article{Zitarska2026,
  author = {Ziętarska, Monika and Małgorzewicz, Sylwia},
  title = {Quality of Life of Colorectal Cancer Patients Treated with Chemotherapy},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18020191}
}
Kostenlos starten →